United Kingdom

Aakash B

CORRECTED-UPDATE 2-AstraZeneca's lung disease treatment gets FDA nod (July 24)

28 Jul 2020

July 24 The U.S. Food and Drug Administration approved AstraZeneca's drug to treat patients with a form of lung disease, the British drugmaker said on Friday.

AstraZeneca diabetes drug shows promise in severe kidney condition

28 Jul 2020

AstraZeneca's diabetes treatment has shown promise in a late-stage trial to help to slow chronic kidney disease, putting it on track for possible expanded approvals ahead of rival drugs.

Synairgen soars after drug shows promise in COVID-19 cases

20 Jul 2020

Synairgen shares rose almost sixfold on Monday after the drugmaker said its medicine helped reduce the risk of severe cases in hospitalised patients with COVID-19, but some experts have cautioned against too much optimism in the market.

Wall Street analysts look past Netflix's weak subscriber forecast

17 Jul 2020

Wall Street analysts shrugged off Netflix Inc's weak third-quarter subscriber forecast, as it racked up a record number of users in the first half of the year, allaying worries about competition from new players such as Disney+ and HBO MAX.

GSK planea fabricar 1.000 mln dosis de adyuvantes para vacuna COVID-19

28 May 2020

May 28 GSK, el mayor fabricante de vacunas del mundo, presentó el jueves planes para producir 1.000 millones de dosis de un refuerzo de la vacuna para el COVID-19 el próximo año, en medio de la carrera por desarrollar una solución exitosa a la crisis del coronavirus.

GSK aims for one billion doses of booster as COVID-19 vaccine race heats up

28 May 2020

GSK , the world's largest vaccine maker, laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters for COVID-19 shots next year, as the race to develop a successful solution to the coronavirus crisis heats up.

ABD AstraZeneca'nın geliştirmekte olduğu koronavirüs aşısından 300 milyon doz sipariş etti

22 May 2020

BENGALURU/LONDRA, 22 Mayıs ABD, İngiliz ilaç şirketi AstraZeneca'nın geliştirmekte olduğu koronavirüs aşısından 300 milyon doz sipariş etti.

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine

22 May 2020

BENGALURU/LONDON The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work. | Video

EUA garantem 300 milhões de doses de possível vacina contra Covid-19 da AstraZeneca

21 May 2020

BENGALURU/LONDRES, 21 Mai Os Estados Unidos garantiram quase um terço do 1 bilhão de doses de uma possível vacina contra Covid-19 da AstraZeneca com uma promessa de até 1,2 bilhão de dólares no momento em que as maiores potências do mundo se apressam em conseguir medicamentos contra a doença e poder reativar suas economias.

World News